Human papillomavirus (HPV) is the most common sexually transmitted infection. In addition to causing cervical cancers, HPV is responsible for 90% of anal cancers and 70% of oropharyngeal cancers, and affects both men and women. This activity provides an update on the prevention of HPV-related cancers and the newly expanded vaccine indications.
This lecture will discuss the appropriate follow-up of patients treated for the most common cancers. This will include breast cancer, colorectal cancer, Hodgkin's and non-Hodgkin's lymphoma, prostate cancer, and lung cancer. An in-depth discussion of the physical challenges and psychological impacts of a cancer diagnosis and its treatment will prepare you to help your patients with what lies ahead.